Literature DB >> 21697012

Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement.

Tim Willinger1, Anthony Rongvaux, Till Strowig, Markus G Manz, Richard A Flavell.   

Abstract

Human hemato-lymphoid-system mice hold great promise for modeling and studying important human diseases in vivo, and to enable vaccine testing. Until now, several major limitations have restricted the utility of human hemato-lymphoid-system mice in translational research. Recently, however, significant advances have been made in improving these mice, based on the delivery of human cytokines to create a better environment for human cells in the mouse host. In this review, we discuss the various approaches with a particular focus on improving human hemato-lymphoid-system mice by human cytokine knock-in gene replacement.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697012     DOI: 10.1016/j.it.2011.04.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  57 in total

Review 1.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 2.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 3.  Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells.

Authors:  Zheng Hu; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

4.  A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.

Authors:  Nicolas Legrand; Gisela J van der Velden; Raphaël Ho Tsong Fang; Marc Douaisi; Kees Weijer; Atze T Das; Bianca Blom; Christel H Uittenbogaart; Ben Berkhout; Mireille Centlivre
Journal:  J Gen Virol       Date:  2012-05-30       Impact factor: 3.891

Review 5.  Humoral immunity in humanized mice: a work in progress.

Authors:  Edward Seung; Andrew M Tager
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

6.  Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice.

Authors:  Eva Billerbeck; Rachael N Labitt; Kevin Vega; Natalia Frias-Staheli; Marcus Dorner; Jing W Xiao; Charles M Rice; Alexander Ploss
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

7.  Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line.

Authors:  Jacqueline S Coats; Ineavely Baez; Cornelia Stoian; Terry-Ann M Milford; Xiaobing Zhang; Olivia L Francis; Ruijun Su; Kimberly J Payne
Journal:  J Vis Exp       Date:  2017-05-10       Impact factor: 1.355

8.  Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models.

Authors:  Trisha R Sippel; Stefan Radtke; Tayla M Olsen; Hans-Peter Kiem; Anthony Rongvaux
Journal:  Blood Adv       Date:  2019-02-12

Review 9.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.

Authors:  Mark Wunderlich; Ryan A Brooks; Rushi Panchal; Garrett W Rhyasen; Gwenn Danet-Desnoyers; James C Mulloy
Journal:  Blood       Date:  2014-04-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.